Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemoglobin subunit theta 1 is a member of the human alpha-globin gene cluster, encoding a globin protein that is mainly expressed in fetal erythroid tissues in very early embryonic development. Unlike the major adult hemoglobins, theta-globin is predominately absent from adult erythroid tissues. Its primary roles include oxygen transport as part of fetal hemoglobin, and emerging evidence points to a regulatory or antioxidative function in non-erythroid cells, particularly in cancer where its overexpression is linked to increased cell proliferation and poor clinical outcome in lung adenocarcinoma. The gene is located on chromosome 16 within the alpha-globin cluster, and its sequence shares homology but not identity with other alpha-globin subunits, suggesting a distinct functional role in development and disease.
For drugs that would theoretically target this molecule, mechanisms might include inhibition of oncogenic functions (cell proliferation), modulation of oxygen transport or antioxidant capacity, but no such drugs are documented in current sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin subunit theta 1 (HBQ1).